NASDAQ: RCKTRocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?
Insider buying vs selling
Have Rocket Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Elisabeth Bjork | Director | 2026-01-02 | 10,000 | $3.44 | $34.40kBuy |
| Martin Wilson | General Counsel | 2025-11-18 | 1,646 | $2.98 | $4.91kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-11-18 | 1,086 | $2.98 | $3.24kSell |
| Jonathan David Schwartz | Chief Science Gene Therapy Officer | 2025-11-18 | 2,545 | $2.98 | $7.59kSell |
| Gaurav Shah | CEO | 2025-11-18 | 6,276 | $2.98 | $18.72kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-10-14 | 5,514 | $3.97 | $21.86kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-10-14 | 3,005 | $3.97 | $11.93kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-10-14 | 558 | $3.98 | $2.22kSell |
| John Militello | Vice President of Finance Treasurer Principal Accounting Officer | 2025-10-14 | 19,841 | $3.96 | $78.57kSell |
| Rtw Investments LP | Director | 2025-09-19 | 1,000,000 | $40.03 | $40.03MBuy |
RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RCKT insiders and whales buy or sell their stock.
RCKT Shareholders
What type of owners hold Rocket Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Roderick Wong | 31.89% | 34,508,759 | $112.84M | Insider |
| Rtw Investments LP | 31.14% | 33,696,243 | $110.19M | Insider |
| Vanguard Group Inc | 7.90% | 8,544,423 | $27.94M | Institution |
| Blackrock Inc | 7.31% | 7,906,071 | $25.85M | Institution |
| Citigroup Inc | 4.85% | 5,246,349 | $17.16M | Institution |
| Morgan Stanley | 3.64% | 3,941,377 | $12.89M | Institution |
| Devon Park Associates LP | 3.01% | 3,253,566 | $10.64M | Insider |
| Devang Kantesaria | 3.00% | 3,243,709 | $10.61M | Insider |
| Devon Park Bioventures LP | 3.00% | 3,243,709 | $10.61M | Insider |
| Monaco Asset Management Sam | 2.76% | 2,987,296 | $9.77M | Institution |
RCKT vs Biotech Stocks
Rocket Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.